Author Question: Which of the following determines effectiveness of high-frequency external chest wall compres-sion ... (Read 34 times)

lindiwe

  • Hero Member
  • *****
  • Posts: 577
Which of the following determines effectiveness of high-frequency external chest wall compres-sion therapy? 1. Compression frequency 2. Largest volumes 3. Flow bias
 
  a. 1 only
  b. 2 only
  c. 1 and 3 only
  d. 2 and 3 only

Question 2

What duration of time and pressure is recommended when using MIE devices to clear airways secretions in adults?
 
  a. 30 to 50 cm H2O at 1 to 3 sec
  b. 10 to 30 cm H2O at 1 to 3 sec
  c. 30 to 50 cm H2O at 5 to 10 sec
  d. 10 to 30 cm H2O at 5 to 10 sec



jaaaaaaa

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

ANS: C
Compression frequency and flow bias (inspiratory vs. expiratory) determine the effectiveness of therapy.

Answer to Question 2

ANS: A
The recommended starting pressure and time for applying MIE to adults is 30 to 50 cm H2O at 1 to 3 sec. From there, pressures can be adjusted accordingly.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library